PATENT CLAIM ANALYSIS

Application Number: 15773524
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["424", "234100"]

Abstract:
The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject.

Claim (Index 7):
The recombinant virulence attenuated Gram-negative bacterial strain for use according to  claim 1 , wherein the heterologous protein is selected from the group consisting of proteins involved in apoptosis or apoptosis regulation, cell cycle regulators, ankyrin repeat proteins, cell signaling proteins, reporter proteins, transcription factors, proteases, small GTPases, GPCR related proteins, nanobody fusion constructs and nanobodies, bacterial T3SS effectors, bacterial T4SS effectors and viral proteins.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 93.0
- Lexical Diversity: 1.13043
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15039116', '13364437', '10818071', '15565609', '09763620']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7444347717302536
- 35 USC 102 Novelty (BERT): 0.520504852337718
- Combined Prediction Score: 0.722041779791
- Mean Citation Score: 279.251184
- Max Citation Score: 299.61252
- Similarity Product: 208.585668642869

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test